| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-48090 | |||
| Azide and BSA Free | NBP2-86683 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-54569-100ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47739-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26608-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-33196 | |||
| IHC-Prediluted | NBP2-44558 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47741-0.1mg | |||
| IHC-Prediluted | NBP2-48203 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-21512-50ul | |||
![Immunohistochemistry-Paraffin: c-Myc Antibody (MYC909) [NBP2-45146] - Human Cervical Carcinoma stained with c-myc Monoclonal Antibody (MYC909).](http://images.novusbio.com/fullsize/c-Myc-Antibody-MYC909-Immunohistochemistry-Paraffin-NBP2-45146-img0001.jpg "Immunohistochemistry-Paraffin: c-Myc Antibody (MYC909) [NBP2-45146] - Human Cervical Carcinoma stained with c-myc Monoclonal Antibody (MYC909).")
![Immunohistochemistry-Paraffin: TSHR Antibody (SPM223) [NBP2-53217] - Formalin-fixed, paraffin-embedded human Thyroid Carcinoma stained with TSHRA Monoclonal Antibody (SPM223).](http://images.novusbio.com/fullsize/TSHR-Antibody-SPM223-Immunohistochemistry-Paraffin-NBP2-53217-img0001.jpg "Immunohistochemistry-Paraffin: TSHR Antibody (SPM223) [NBP2-53217] - Formalin-fixed, paraffin-embedded human Thyroid Carcinoma stained with TSHRA Monoclonal Antibody (SPM223).")
![Immunohistochemistry-Paraffin: c-Myc Antibody (MYC275 + MYC909) [NBP2-45147] - Human Cervical Carcinoma stained with c-myc Monoclonal Antibody (MYC275 + MYC909).](http://images.novusbio.com/fullsize/c-Myc-Antibody-MYC275-+-MYC909-Immunohistochemistry-Paraffin-NBP2-45147-img0001.jpg "Immunohistochemistry-Paraffin: c-Myc Antibody (MYC275 + MYC909) [NBP2-45147] - Human Cervical Carcinoma stained with c-myc Monoclonal Antibody (MYC275 + MYC909).")
![Immunohistochemistry: E2F-4 Antibody (24E12) [NBP3-26608] - Image of E2F-4 Antibody (24E12) diluted at 1:100 and staining in paraffin-embedded human brain tissue performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a Goat anti-rabbit polymer IgG labeled by HRP and visualized using 0.05% DAB.](http://images.novusbio.com/fullsize/nbp3-26608_rabbit-e2f-4-mab-24e12-262202414471533.jpg "Immunohistochemistry: E2F-4 Antibody (24E12) [NBP3-26608] - Image of E2F-4 Antibody (24E12) diluted at 1:100 and staining in paraffin-embedded human brain tissue performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a Goat anti-rabbit polymer IgG labeled by HRP and visualized using 0.05% DAB.")
![Flow Cytometry: E2F-4 Antibody (24E12) [NBP3-26608] - Overlay Peak curve showing MCF7 cells stained with E2F-4 Antibody (24E12) (red line) at 1:100. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.](http://images.novusbio.com/fullsize/nbp3-26608_rabbit-e2f-4-mab-24e12-282202414312787.jpg)
![Immunocytochemistry/Immunofluorescence: E2F-4 Antibody (24E12) [NBP3-26608] -Immunofluorescence staining of Hela cell with E2F-4 Antibody at 1:50, counter-stained with DAPI. The cells were fixed in 4% formaldehyde and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4°C. The secondary antibody was Alexa Fluor 513-congugated AffiniPure Goat Anti-Rabbit IgG(H+L).](http://images.novusbio.com/fullsize/nbp3-26608_rabbit-e2f-4-mab-24e12-29120251248506.jpg)
![Various whole cell extracts (30 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with TCP1 eta antibody [C1C3] (NBP2-20588) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/nbp2-20588_rabbit-polyclonal-tcp1-eta-antibody-western-blot-2611202518281024.jpg "Various whole cell extracts (30 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with TCP1 eta antibody [C1C3] (NBP2-20588) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.")
![Whole cell extract (30 ug) was separated by 10% SDS-PAGE, and the membrane was blotted with TCP1 eta antibody [C1C3] (NBP2-20588) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/nbp2-20588_rabbit-polyclonal-tcp1-eta-antibody-western-blot-2611202518331022.jpg)
![Immunohistochemistry-Paraffin: CD30/TNFRSF8 Antibody (CD30/412) [NBP2-29425] - Formalin-fixed, paraffin-embedded Hodgkin's lymphoma (20X) stained with CD30 Ab (CD30/412).](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-CD30-412-Immunohistochemistry-Paraffin-NBP2-29425-img0006.jpg "Immunohistochemistry-Paraffin: CD30/TNFRSF8 Antibody (CD30/412) [NBP2-29425] - Formalin-fixed, paraffin-embedded Hodgkin's lymphoma (20X) stained with CD30 Ab (CD30/412).")
![Immunohistochemistry-Paraffin: CD30/TNFRSF8 Antibody (CD30/412) [NBP2-29425] - Formalin-fixed, paraffin-embedded Hodgkin's lymphoma(20X) stained with CD30 Ab (CD30/412).](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-CD30-412-Immunohistochemistry-Paraffin-NBP2-29425-img0005.jpg)
![Immunohistochemistry-Paraffin: EGFR Antibody (SPM622) [NBP2-45149] - Human Placenta stained with EGFR Monoclonal Antibody (SPM622).](http://images.novusbio.com/fullsize/EGFR-Antibody-SPM622-Immunohistochemistry-Paraffin-NBP2-45149-img0001.jpg "Immunohistochemistry-Paraffin: EGFR Antibody (SPM622) [NBP2-45149] - Human Placenta stained with EGFR Monoclonal Antibody (SPM622).")
![Western Blot: RFC1 Antibody [NB100-230] - Samples: Whole cell lysate (0.5 or 1.0 mg per IP reaction; 20% of IP loaded) from HeLa cells prepared using NETN lysis buffer. Antibodies: Affinity purified rabbit anti-RFC1 antibody (lot was used at 0.4 ug/ml. Detection: Chemiluminescence with an exposure time of 10 seconds.](http://images.novusbio.com/fullsize/RFC1-Antibody-Western-Blot-NB100-230-img0089.jpg "Western Blot: RFC1 Antibody [NB100-230] - Samples: Whole cell lysate (0.5 or 1.0 mg per IP reaction; 20% of IP loaded) from HeLa cells prepared using NETN lysis buffer. Antibodies: Affinity purified rabbit anti-RFC1 antibody (lot was used at 0.4 ug/ml. Detection: Chemiluminescence with an exposure time of 10 seconds.")
![<b>Biological Strategies Validation. </b>Western Blot: RFC1 Antibody [NB100-230] - Samples: Whole cell lysate (50, 15 ug) from HeLa and 293T cells prepared using NETN lysis buffer. Antibody: Affinity purified rabbit anti-RFC1 antibody used for WB at 0.1 ug/ml. Detection: Chemiluminescence with an exposure time of 30 seconds.](http://images.novusbio.com/fullsize/RFC1-Antibody-Western-Blot-NB100-230-img0088.jpg)
![Immunohistochemistry: TOB2 Antibody - BSA Free [NBP3-45166] - Immunohistochemistry of paraffin-embedded human liver injury tissue slide using ( TOB2 Antibody) at dilution of 1:100](http://images.novusbio.com/fullsize/nbp3-45166_rabbit-tob2-pab-bsa-free-284202511333234.jpg "Immunohistochemistry: TOB2 Antibody - BSA Free [NBP3-45166] - Immunohistochemistry of paraffin-embedded human liver injury tissue slide using ( TOB2 Antibody) at dilution of 1:100")
![Western Blot: TOB2 Antibody - BSA Free [NBP3-45166] - MCF7 cells were subjected to SDS PAGE followed by western blot with ( TOB2 Antibody) at dilution of 1:1000](http://images.novusbio.com/fullsize/nbp3-45166_rabbit-tob2-pab-bsa-free-284202511352262.jpg)
![Western Blot: E-Cadherin [p Ser838, p Ser840] Antibody (S03-3B3) [NBP3-19826] - Western blot detection of E-Cadherin (phospho-Ser838/Ser840) in HepG2, U2OS, U251, Lncap using NBP3-19826 (1:1000 diluted)](http://images.novusbio.com/fullsize/E-Cadherin-p-Ser838-p-Ser840-Antibody-S03-3B3-Western-Blot-NBP3-19826-img0002.jpg "Western Blot: E-Cadherin [p Ser838, p Ser840] Antibody (S03-3B3) [NBP3-19826] - Western blot detection of E-Cadherin (phospho-Ser838/Ser840) in HepG2, U2OS, U251, Lncap using NBP3-19826 (1:1000 diluted)")
![Immunohistochemistry-Paraffin: E-Cadherin [p Ser838, p Ser840] Antibody (S03-3B3) [NBP3-19826] - Immunohistochemistry of E-Cadherin (phospho-Ser838/Ser840) in paraffin-embedded Human breast cancer tissue using NBP3-19826 at dilution 1/50](http://images.novusbio.com/fullsize/E-Cadherin-p-Ser838-p-Ser840-Antibody-S03-3B3-Immunohistochemistry-Paraffin-NBP3-19826-img0001.jpg)
![Western Blot: PP2A alpha [p Tyr 307] Antibody (SR1588) [NBP3-21512] - Western blot analysis using NBP3-21512 in (1) Rat kidney lysate; (2) A431 cell lysate treated with EGF.](http://images.novusbio.com/fullsize/nbp3-21512_rabbit-pp2a-alpha-p-tyr-307-mab-sr1588-6720239533772.jpg "Western Blot: PP2A alpha [p Tyr 307] Antibody (SR1588) [NBP3-21512] - Western blot analysis using NBP3-21512 in (1) Rat kidney lysate; (2) A431 cell lysate treated with EGF.")